❌

Reading view

Hera: Learning Long-Horizon Coordination for Device-Cloud Collaborative LLM Agents

arXiv:2605.24598v1 Announce Type: new Abstract: Large language model (LLM) agents excel at solving complex long-horizon tasks through autonomous interaction with environments. However, their real-world deployment faces a fundamental device--cloud dilemma: on-device models are efficient but often brittle, while cloud models are stronger but costly in computation. State-of-the-art LLM device--cloud routers usually make coarse task-level decisions, which cannot adapt to the changing difficulty of multi-step agent interactions. To address this issue, we present Hera, a step-level device--cloud LLM agent coordinator for long-horizon tasks achieving a strong performance--cost Pareto frontier. Hera adopts a novel two-stage training paradigm: (1) imitation learning for cold-start, followed by (2) reinforcement learning that jointly optimizes task success and cloud usage efficiency. The first stage casts step-level routing as a supervised classification problem: the device agent is replayed on cloud trajectories, with each state labeled by the agreement between device and cloud actions. In the second stage, we perform cost-aware reinforcement learning by grouping identical states across trajectories and updating Hera with labels favoring higher expected return and fewer future cloud calls. We evaluate Hera on ALFWorld, WebShop, and AppWorld, where it consistently outperforms prior methods, achieving 92.5% of the cloud-only success rate with cloud use in only 46.3% of steps.
  •  

Spatial Omics in Gastrointestinal Oncology: Recent Advances, Therapeutic Insights, and Clinical Translation

J Cancer. 2026 Jan 30;17(3):515-523. doi: 10.7150/jca.127381. eCollection 2026.

ABSTRACT

Gastrointestinal (GI) cancers remain a leading cause of cancer-related morbidity and mortality worldwide, largely due to their molecular heterogeneity, complex tumor microenvironment (TME), and variable treatment responses. In recent years, the emergence of spatially resolved omics technologies-encompassing spatial transcriptomics, proteomics, metabolomics, and epigenomics-has revolutionized the ability to interrogate tumor architecture with unprecedented resolution. These methods enable precise mapping of cellular and molecular interactions within intact tissue contexts, thereby uncovering spatially defined niches that influence tumor progression, immune evasion, and therapeutic resistance. In GI malignancies such as colorectal, gastric, and esophageal cancers, spatial omics have provided critical insights into cancer-stromal-immune crosstalk, identified predictive biomarkers for immunotherapy and targeted agents, and guided the development of novel therapeutic strategies. This review synthesizes the latest advances in spatial omics applied to GI oncology over the past five years, with an emphasis on their integration into early diagnosis, treatment stratification, and real-time monitoring of therapeutic efficacy. We also discuss current challenges, including standardization, data integration, and clinical validation, as well as future directions for incorporating spatial profiling into routine oncology practice. By bridging the gap between bench discoveries and bedside applications, spatial omics hold transformative potential for achieving truly personalized treatment in gastrointestinal cancers.

PMID:41869445 | PMC:PMC13003551 | DOI:10.7150/jca.127381

  •  

MEBM-Phoneme: Multi-scale Enhanced BrainMagic for End-to-End MEG Phoneme Classification

arXiv:2603.02254v1 Announce Type: cross Abstract: We propose MEBM-Phoneme, a multi-scale enhanced neural decoder for phoneme classification from non-invasive magnetoencephalography (MEG) signals. Built upon the BrainMagic backbone, MEBM-Phoneme integrates a short-term multi-scale convolutional module to augment the native mid-term encoder, with fused representations via depthwise separable convolution for efficient cross-scale integration. A convolutional attention layer dynamically weights temporal dependencies to refine feature aggregation. To address class imbalance and session-specific distributional shifts, we introduce a stacking-based local validation set alongside weighted cross-entropy loss and random temporal augmentation. Comprehensive evaluations on LibriBrain Competition 2025 Track2 demonstrate robust generalization, achieving competitive phoneme decoding accuracy on the validation and official test leaderboard. These results underscore the value of hierarchical temporal modeling and training stabilization for advancing MEG-based speech perception analysis.
  •  

MEBM-Speech: Multi-scale Enhanced BrainMagic for Robust MEG Speech Detection

arXiv:2603.02255v1 Announce Type: cross Abstract: We propose MEBM-Speech, a multi-scale enhanced neural decoder for speech activity detection from non-invasive magnetoencephalography (MEG) signals. Built upon the BrainMagic backbone, MEBM-Speech integrates three complementary temporal modeling mechanisms: a multi-scale convolutional module for short-term pattern extraction, a bidirectional LSTM (BiLSTM) for long-range context modeling, and a depthwise separable convolutional layer for efficient cross-scale feature fusion. A lightweight temporal jittering strategy and average pooling further improve onset robustness and boundary stability. The model performs continuous probabilistic decoding of MEG signals, enabling fine-grained detection of speech versus silence states - an ability crucial for both cognitive neuroscience and clinical applications. Comprehensive evaluations on the LibriBrain Competition 2025 Track1 benchmark demonstrate strong performance, achieving an average F1 macro of 89.3% on the validation set and comparable results on the official test leaderboard. These findings highlight the effectiveness of multi-scale temporal representation learning for robust MEG-based speech decoding.
  •  
❌